The system includes a QX200 droplet generator and reader, dedicated computer, QuantaSoft software and associated component consumables. For over six decades, Bio-Rad has served life science research ...

A number of other equities analysts have also recently weighed in on the stock. Wells Fargo & Company started coverage on ...

Bio-Rad Laboratories is buying back a considerable amount of its own stock given the shares' current valuation and growth prospects. Profits and sales are expected to rebound in FY2025.

Illumina Miseq and real-time PCR equipment is available for deep-sequencing, transcriptome analyses, etc. To book, please visit the following website. In addition, two Bio-Rad QX200 digital PCR ...

We recently compiled a list of the 10 Best Organ Transplant and Diagnosis Stocks To Buy Now. In this article, we are going to take a look at where Bio-Rad Laboratories, Inc. (NYSE:BIO) stands against ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

After bluebird bio acknowledged troubles keeping its business operational, the gene therapy biotech is launching a restructuring that will reduce the size of its workforce by about 25%.

Oct. 17, 2024 — Researchers identify the crucial protein for controlling the biosynthesis of steroidal glycoalkaloids and saponins in plants of the genus Solanum and ...

If you're writing a corporate bio, highlight your achievements within the company. Avoid generic statements and be truthful when describing your skills and experiences. Focus on your unique ...